Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000947871-00-000178
Filing Date
2000-02-24
Accepted
2000-02-24 00:00:00
Documents
1
Group Members
CADUCEUS CAPITAL TRUSTFINSBURY WORLDWIDE PHARMACEUTICAL TRUSTORBIMED ADVISERS INC /CTORBIMED ADVISORS LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D SC 13D 22554
  Complete submission text file 0000947871-00-000178.txt   24781
Mailing Address 350 MAIN STREET SUITE 307 DOYLESTOWN PA 18901
Business Address 350 MAIN STREET SUITE 307 DOYLESTOWN PA 18901 2152404699
DISCOVERY LABORATORIES INC /DE/ (Subject) CIK: 0000946486 (see all company filings)

EIN.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-48329 | Film No.: 552160
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address 41 MADISON AVENUE 40TH FLOOR NEW YORK NY 10010 2126850800
ORBIMED ADVISERS INC /CT (Filed by) CIK: 0001033248 (see all company filings)